IMB Dx, Inc. (KOSDAQ:461030)
South Korea · Delayed Price · Currency is KRW 2,965.00
-35.00 (-1.17%)
Jul 21, 2026, 3:30 PM KST
IMB Dx Market Cap
IMB Dx has a market cap or net worth of 42.05 billion as of July 21, 2026. Its market cap has decreased by -64.37% in one year.
Market Cap
42.05B
Enterprise Value
23.09B
Revenue
5.60B
Ranking
n/a
PE Ratio
n/a
Stock Price
2,965.00
ChartMarket Cap Chart
Since April 3, 2024, IMB Dx's market cap has decreased from 503.73B to 42.05B, a decrease of -91.65%. That is a compound annual growth rate of -66.05%.
| Date | Market Cap | % Change |
|---|---|---|
| Jul 21, 2026 | 42.05B | -69.67% |
| Dec 30, 2025 | 138.64B | -7.14% |
| Dec 30, 2024 | 149.29B | -70.36% |
| Apr 3, 2024 | 503.73B | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Vaxcell-Bio Therapeutics | 96.40B |
| MedPacto | 92.37B |
| Amicogen | 82.36B |
| iNtRON Biotechnology | 79.35B |
| ENCell | 72.13B |
| CG Invites | 67.97B |
| Prestige BioPharma | 63.58B |
| ORIENT BIO | 52.47B |